Amgen recalls anemia drugs due to glass flakes

Sep 24, 2010

(AP) -- Amgen Inc. is recalling some lots of its Epogen and Procrit anemia treatments because they may contain glass flakes.

The Thousand Oaks, Calif., biotechnology company says the flakes are barely visible in most cases, and they have fielded no complaints or reports about problems that can be directly tied to them.

Amgen says the flakes are caused by the interaction of the drug with glass vials over the product's shelf life.

The affected lot numbers and expiration dates can be found on Web sites for the products.

Epogen treats in patients with chronic renal failure who are on dialysis. Procrit also treats it for on and some HIV-infected patients.

Explore further: 'The process by which drugs are discovered and developed will be fundamentally different in the future'

More information: http://www.epogen.com , http://www.procrit.com .

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Anemia drugs under scrutiny

Mar 13, 2008

U.S. drug regulators are contemplating further restrictions on the use of drugs to combat anemia in cancer patients.

Study finds stroke risk from anemia drug Aranesp

Oct 31, 2009

(AP) -- A new study raises fresh safety concerns about widely used anemia medicines, finding that the drug Aranesp nearly doubled the risk of stroke in people with diabetes and chronic kidney problems who are not yet sick ...

Patient privacy focus of Amgen suit

Jan 09, 2008

Two former employees with the California biotech company Amgen Inc. allege the company persuaded sales people to access patient records to boost sales.

Recommended for you

Discount generic drug programs grow over time

16 hours ago

Generic discount drug programs (GDDPs, which charge nominal fees to fill prescriptions) have grown over time and their initial lower use by racial/ethnic minorities has evaporated, writes author Song Hee Hong, Ph.D., of the ...

Seniors successfully withdraw from meds

Sep 19, 2014

Elderly people have proved receptive to being de-prescribed medications, as part of a trial aimed at assessing the feasibility of withdrawal of medications among older people.

User comments : 0